May 7, 2025

Regulatory Hurdles in Animal Health: Key Considerations for Bringing New Products to Market  

The animal health industry is evolving rapidly, driven by advancements in veterinary medicine, increased demand for innovative treatments, and changing regulatory requirements. Companies seeking to bring new veterinary drugs, biologics, and feed additives to market must navigate a complex regulatory landscape that spans multiple agencies, including the FDA Center for […]
May 7, 2025

Veterinary Biologics: Regulatory Pathways for Faster Market Entry  

Introduction  The demand for veterinary biologics is on the rise as advancements in biotechnology pave the way for innovative treatments in animal health. Unlike traditional pharmaceuticals, veterinary biologics—such as vaccines, monoclonal antibodies, cell and tissue derived products and gene therapies—offer targeted mechanisms of action with fewer side effects. However, navigating […]
May 7, 2025

Navigating Economic Pressures in the Veterinary Sector: Strategies for Sustained Growth 

The veterinary sector is undergoing a transformation driven by economic pressures, shifting consumer behaviors, and evolving regulatory landscapes. Rising costs and changing pet ownership trends have led to a decline in veterinary visits, particularly in the companion animal market. As companies navigate these challenges, optimizing regulatory efficiencies, Chemistry, Manufacturing, and […]
May 7, 2025

Conditional Approvals for Veterinary Drugs: A Faster Path to Market?   

Introduction Bringing a new veterinary drug to market is a time-consuming and resource-intensive process. To address urgent animal health needs, the FDA’s Center for Veterinary Medicine (CVM) offers the Conditional New Animal Drug Approval (CNADA) process, which provides an expedited pathway for certain veterinary drugs. This blog explores how the […]
May 7, 2025

The Rise of Biologicals: How Regulatory Changes Are Shaping the Future of Veterinary Medicines  

The animal health industry is undergoing a significant transformation as biologicals gain traction over traditional pharmaceuticals. Driven by advancements in veterinary biotechnology, shifting market demand, and evolving regulatory frameworks, biologicals are increasingly becoming the preferred choice for disease prevention and treatment in animals. As regulatory agencies like the FDA Center […]
May 6, 2025

The Importance of Analytical Processes in Animal Health Product Development 

When it comes to developing safe, effective, and compliant animal health products, analytical processes play a critical—yet often underappreciated—role. Whether for veterinary pharmaceuticals, biologics, or medicated feeds, the rigor and precision of analytical methods are central to ensuring product quality, consistency, and regulatory approval.  At DSI, we partner with veterinary […]